The Nef protein of HIV-1 induces loss of cell surface costimulatory molecules CD80 and CD86 in APCs

被引:82
作者
Chaudhry, A
Das, SR
Hussain, A
Mayor, S
George, A
Bal, V
Jameel, S [1 ]
Rath, S
机构
[1] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India
[2] Natl Inst Immunol, New Delhi 110067, India
[3] Natl Ctr Biol Sci, Bangalore, Karnataka, India
基金
英国惠康基金;
关键词
D O I
10.4049/jimmunol.175.7.4566
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Nef protein of HIV-1 is essential for its pathogenicity and is known to down-regulate MHC expression on infected cell surfaces. We now show that Nef also redistributes the costimulatory molecules CD80 and CD86 away from the cell surface in the human monocytic U937 cell line as well as in mouse macrophages and dendritic cells. Furthermore, HIV-1-infected U937 cells and human blood-derived macrophages show a similar loss of cell surface CD80 and CD86. Nef colocalizes with MHC class I (MHCI), CD80, and CD86 in intracellular compartments, and binds to both mouse and human CD80 and CD86. Some Nef mutants defective in MHO down-modulation, including one from a clinical isolate, remain capable of down-modulating CD80 and CD86. Nef-mediated loss of surface CD80/CD86 is functionally significant, because it leads to compromised activation of naive T cells. This novel immunomodulatory role of Nef may be of potential importance in explaining the correlations of macrophage-tropism and Nef with HIV-1 pathogenicity and immune evasion.
引用
收藏
页码:4566 / 4574
页数:9
相关论文
共 29 条
  • [11] Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1 - A report from the Sydney Blood Bank Cohort
    Learmont, JC
    Geczy, AF
    Mills, J
    Ashton, LJ
    Raynes-Greenow, CH
    Garsia, RJ
    Dyer, WB
    McIntyre, L
    Oelrichs, RB
    Rhodes, DI
    Deacon, NJ
    Sullivan, JS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (22) : 1715 - 1722
  • [12] CD28/B7 system of T cell costimulation
    Lenschow, DJ
    Walunas, TL
    Bluestone, JA
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 233 - 258
  • [13] The duration of antigenic stimulation determines the fate of naive and effector T cells
    Lezzi, G
    Karjalainen, K
    Lanzavecchia, A
    [J]. IMMUNITY, 1998, 8 (01) : 89 - 95
  • [14] The functional consequences of delivery of HIV-1 Nef to dendritic cells using an adenoviral vector
    Maccormac, LP
    Jacque, JM
    Chain, B
    [J]. VACCINE, 2004, 22 (3-4) : 528 - 535
  • [15] High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection
    Mariani, R
    Kirchhoff, F
    Greenough, TC
    Sullivan, JL
    Desrosiers, RC
    Skowronski, J
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (11) : 7752 - 7764
  • [16] CHANGING VIRUS-HOST INTERACTIONS IN THE COURSE OF HIV-1 INFECTION
    MIEDEMA, F
    MEYAARD, L
    KOOT, M
    KLEIN, MR
    ROOS, MTL
    GROENINK, M
    FOUCHIER, RAM
    VANTWOUT, AB
    TERSMETTE, M
    SCHELLEKENS, PTA
    SCHUITEMAKER, H
    [J]. IMMUNOLOGICAL REVIEWS, 1994, 140 : 35 - 72
  • [17] Oral tolerance in T cells is accompanied by induction of effector function in lymphoid organs after systemic immunization
    Parameswaran, N
    Samuvel, DJ
    Kumar, R
    Thatai, S
    Bal, V
    Rath, S
    George, A
    [J]. INFECTION AND IMMUNITY, 2004, 72 (07) : 3803 - 3811
  • [18] HIV-1 Nef induces dendritic cell differentiation:: A possible mechanism of uninfected CD4+ T cell activation
    Quaranta, MG
    Tritarelli, E
    Giordani, L
    Viora, M
    [J]. EXPERIMENTAL CELL RESEARCH, 2002, 275 (02) : 243 - 254
  • [19] GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway
    Sabharanjak, S
    Sharma, P
    Parton, RG
    Mayor, S
    [J]. DEVELOPMENTAL CELL, 2002, 2 (04) : 411 - 423
  • [20] Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein
    Schwartz, O
    Marechal, V
    LeGall, S
    Lemonnier, F
    Heard, JM
    [J]. NATURE MEDICINE, 1996, 2 (03) : 338 - 342